Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Plc Regulatory News (EML)

Share Price Information for Emmerson Plc (EML)

Share Price is delayed by 15 minutes
Get Live Data
2.10    0.00 (0.00%)
Bid:
2.00
Ask:
2.20
Spread: 0.20 (10.00%)
Market Cap: £28.06m
EML Live PriceLast checked at - London Stock Exchange

Intraday Emmerson Plc Share Chart

Request for Arbitration

1 May 2025 08:10

RNS Number : 0138H
Emmerson PLC
01 May 2025
 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

 

1 May 2025

Emmerson PLC

("Emmerson" or the "Company")

Emmerson Submits Request for Arbitration

Emmerson Plc, the Moroccan focused potash development company, is pleased to provide an update on the dispute with the Kingdom of Morocco in relation to the Khemisset Potash Project in Morocco (the "Project").

· A Request for Arbitration (RFA) has been submitted to the International Centre for Settlement of Investment Disputes (ICSID), an arm of the World Bank with regard to various breaches, by the Government of the Kingdom of Morocco and its Agents, of the Agreement between the Government of the United Kingdom of Great Britain and Northern Ireland and the Government of the Kingdom of Morocco for the Promotion and Protection of Investments, which was signed on 30 October 1990 and entered into force on 14 February 2002 (the "BIT").

·  Emmerson is bringing a claim for full compensation in respect of the Khemisset Potash Project which it had internally valued at $2.2 billion.

·  All the legal costs in relation to the matter as well as a significant portion of G&A costs are to be funded through the $11.2 million litigation funding facility confirmed in January 2025.

· Emmerson, through the Company's legal advisors Boies Schiller Flexner (BSF), are working on the formation of the arbitral tribunal and preparing a formal Memorial submission.

The Request for Arbitration and Next Steps

The lodging of the RFA with ICSID is the first formal step in the arbitration process.

Once the RFA is received by ICSID, copies are to be sent to all relevant parties in the case, being the appropriate people within the Government of the Kingdom of Morocco.

The RFA itself is a document that lays out the general background and details of the case in relation to Morocco's expropriation of the Project. In due course, the Company will make further announcements concerning the constitution of the arbitral tribunal, the filing of written submissions, including a substantiated damages figure, and the evidentiary hearing, which the Company understands will take approximately two years from the submission of the RFA.

Graham Clarke, Managing Director of Emmerson PLC commented:

"The completion and lodgement of the RFA with ICSID is a significant step and marks the formal commencement of the litigation process. The Company is working closely with our lawyers at BSF and as a group we remain confident in the merits of this case. We look forward to providing further updates in due course".

 

**ENDS**

For further information, please visit www.emmersonplc.com, follow us on Twitter

(@emmerson_plc),

or contact: 

Emmerson Plc

Graham Clarke / Hayden Locke

+44 (0) 207 138 3204

Panmure Liberum Limited (Nominated Adviser and Broker)

Scott Mathieson / Will King

+44 (0) 20 3100 2000

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDFLBBEELBBBD
Date   Source Headline
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project
29th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSIssue of Equity & Total Voting Rights
12th Nov 20217:00 amRNSInvestor Presentation
11th Nov 202110:30 amRNSNotice of AGM
11th Nov 20217:00 amRNSDirector/PDMR Shareholding
10th Nov 20219:05 amRNSSecond Price Monitoring Extn
10th Nov 20219:00 amRNSPrice Monitoring Extension
10th Nov 20217:00 amRNSStrategic Investment of up to US$46.75m
30th Sep 20217:01 amRNSOperational Update: Khemisset Potash Project
30th Sep 20217:00 amRNSInterim Results
12th Jul 20217:00 amRNSAppointment of Non-Exec Director & Board Changes
24th Jun 20217:00 amRNSKhemisset Potash Project Update
4th Jun 202111:30 amRNSDirector/PDMR Shareholding
3rd Jun 20212:05 pmRNSSecond Price Monitoring Extn
3rd Jun 20212:00 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSExercise of Warrants and Issue of Shares
21st May 20218:15 amRNSShareholder Call
18th May 20211:15 pmEQSHardman & Co Research: Emmerson Plc (EML): A competitively well-placed potash play
17th May 20217:00 amRNSFinal Results
29th Apr 202111:00 amRNSYellowstone Advisory Event
27th Apr 202112:40 pmEQSHardman & Co Research : Hardman & Co Video Event | Emmerson Plc - Investor Forum
27th Apr 20217:00 amRNSAdmission to AIM and Appointment of Chairman
21st Apr 20211:32 pmRNSSchedule One update - Emmerson plc
15th Apr 20217:00 amRNSUpdate on Phased Development Strategy
12th Apr 20217:00 amRNSExercise of Warrants and Issue of Shares
1st Apr 20211:30 pmRNSLondon South East Investor Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.